Cargando…
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice
Histamine receptor 2 (H2) antagonists are widely used clinically for the control of gastrointestinal symptoms, but also impact immune function. They have been reported to reduce tumor growth in established colon and lung cancer models. Histamine has also been reported to modify populations of myeloi...
Autores principales: | Vila-Leahey, Ava, Oldford, Sharon A., Marignani, Paola A., Wang, Jun, Haidl, Ian D., Marshall, Jean S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006904/ https://www.ncbi.nlm.nih.gov/pubmed/27622015 http://dx.doi.org/10.1080/2162402X.2016.1151591 |
Ejemplares similares
-
Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response
por: Rogers, Dakota, et al.
Publicado: (2018) -
The impact of ranitidine on monocyte responses in the context of solid tumors
por: Vila-Leahey, Ava, et al.
Publicado: (2016) -
Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects
por: Meghnem, Dihia, et al.
Publicado: (2021) -
Local Toll-like receptor-mediated mast cell activation inhibits melanoma growth
por: Oldford, SA, et al.
Publicado: (2010) -
Interferon α2 and interferon γ induce the degranulation independent production of VEGF‐A and IL‐1 receptor antagonist and other mediators from human mast cells
por: Oldford, Sharon A., et al.
Publicado: (2017)